Advanced HIV: Outcomes for Rapid ART

Condition:   HIV-1-infection Intervention:   Drug: Bictegravir/emtricitabine/tenofovir alafenamide Sponsors:   Valley AIDS Council;   Gilead Sciences Not yet recruiting

Source: ClinicalTrials.gov - September 2, 2022 Category: Research Source Type: clinical trials